Showing results (6641-6650 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|April 15, 2010
A pilot study on prostate cancer risk and pro-inflammatory genotypes: pathophysiology and therapeutic implicationsC R Balistreri, C Caruso, G Carruba, et al.Current Pharmaceutical Design|April 15, 2010
Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular associationS Petta, A CraxìCurrent Pharmaceutical Design|April 15, 2010
Administration of a synbiotic to free-living elderly and evaluation of serum cytokines. A pilot studyL Amati, G Marzulli, M Martulli, et al.Current Pharmaceutical Design|April 15, 2010
Donkey and goat milk intake and modulation of the human aged immune responseL Amati, G Marzulli, M Martulli, et al.Current Pharmaceutical Design|July 16, 2009
Comprehensive assessment of ADMET risks in drug discoveryJianling WangCurrent Pharmaceutical Design|July 16, 2009
The role of hyphenated chromatography-mass spectrometry techniques in exploratory drug metabolism and pharmacokineticsYunsheng Hsieh, Walter KorfmacherCurrent Pharmaceutical Design|July 16, 2009
ADAM10 as a therapeutic target for cancer and inflammationHoward C Crawford, Peter J Dempsey, Gordon Brown, et al.Current Pharmaceutical Design|July 16, 2009
Targeting ADAM12 in human disease: head, body or tail?J Jacobsen, U M WewerCurrent Pharmaceutical Design|July 16, 2009
The therapeutic potential of ADAM15Neali Lucas, Abdo J Najy, Mark L DayCurrent Pharmaceutical Design|July 16, 2009
ADAM19/adamalysin 19 structure, function, and role as a putative target in tumors and inflammatory diseasesBin Qi, Robert G Newcomer, Qing-Xiang Amy SangPageof 1,008